慢性阻塞性肺疾病基金会成立二十周年。
The COPD Foundation on Its Twentieth Anniversary.
作者信息
Malanga Elisha, Thomashow Byron, Wright Jean, Walsh Linda, Carlomagno Cathy Gray, Sullivan Jamie, Williams Stephanie, Miller Bruce E, Rothhaar Crystal, Clark William, Hamilton Alan, Hess Michael, Prieto Oliver Delia, Malanga Vincent, Amari Peter, Crapo James, Mannino David M
机构信息
COPD Foundation, Miami, Florida, United States.
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University, New York, NY.
出版信息
Chronic Obstr Pulm Dis. 2024 May 29;11(3):247-260. doi: 10.15326/jcopdf.2024.0527.
Abstract
This article does not contain an abstract.
摘要
本文不包含摘要。
相似文献
1
The COPD Foundation on Its Twentieth Anniversary.慢性阻塞性肺疾病基金会成立二十周年。
Chronic Obstr Pulm Dis. 2024 May 29;11(3):247-260. doi: 10.15326/jcopdf.2024.0527.
2
The COPD Foundation: Celebrating a Decade of Progress and Looking Ahead to a Cure.慢性阻塞性肺疾病基金会：庆祝十年进展并展望治愈之未来。
Chronic Obstr Pulm Dis. 2014 May 6;1(1):4-16. doi: 10.15326/jcopdf.1.1.2014.0122.
3
Twentieth anniversary of American Vascular Association/Lifeline Foundation: a celebration.美国血管协会/生命线基金会成立二十周年：庆典活动
J Vasc Surg. 2008 Jun;47(6):1351-5. doi: 10.1016/j.jvs.2008.03.026. Epub 2008 Apr 28.
4
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.介绍 COPD 基金会 COPD 诊断和管理指南，这是 COPD 基金会的建议。
COPD. 2013 Jun;10(3):378-89. doi: 10.3109/15412555.2013.801309.
5
A meta-analysis on the impact of disease-specific education programs on health outcomes for patients with chronic obstructive pulmonary disease.疾病特异性教育计划对慢性阻塞性肺疾病患者健康结局影响的荟萃分析。
Geriatr Nurs. 2012 Jul-Aug;33(4):280-96. doi: 10.1016/j.gerinurse.2012.03.001. Epub 2012 May 16.
6
Editorial-2014-2024: Celebrating 10 Years of Nonprofit, Open-Access Publishing Focused on COPD, Bronchiectasis, and Nontuberculous Mycobacteria Research.社论 - 2014 - 2024：庆祝非营利性开放获取出版十周年，专注于慢性阻塞性肺疾病、支气管扩张症和非结核分枝杆菌研究。
Chronic Obstr Pulm Dis. 2024 Jan 25;11(1):1-2. doi: 10.15326/jcopdf.2024.0497.
7
β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease - A Danish Nationwide Study of 1·3 Million Individuals.β受体阻滞剂治疗与慢性阻塞性肺疾病风险——一项对130万丹麦人的全国性研究
EClinicalMedicine. 2019 Jan 29;7:21-26. doi: 10.1016/j.eclinm.2019.01.004. eCollection 2019 Jan.
8
Integrating COPD into Patient-Centered Hospital Readmissions Reduction Programs.将慢性阻塞性肺疾病纳入以患者为中心的减少医院再入院计划。
Chronic Obstr Pulm Dis. 2015;2(1):70-80. doi: 10.15326/jcopdf.2.1.2014.0148.
9
Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient- Powered Registry Network.慢性阻塞性肺疾病基金会患者驱动注册网络中自我报告的慢性阻塞性肺疾病药物使用情况及依从性
Chronic Obstr Pulm Dis. 2021 Oct 28;8(4):474-487. doi: 10.15326/jcopdf.2021.0252.
10
Improving Interprofessional and Coproductive Outcomes of Care for Patients with Chronic Obstructive Pulmonary Disease.改善慢性阻塞性肺疾病患者的跨专业协作及共同生产性照护结局
BMJ Qual Improv Rep. 2016 Jun 17;5(1). doi: 10.1136/bmjquality.u210329.w4679. eCollection 2016.
引用本文的文献
1
Are We Getting Closer to the "Cholesterol" for Chronic Respiratory Disease?我们离慢性呼吸道疾病的“胆固醇”（指标）更近了吗？
Am J Respir Crit Care Med. 2024 Sep 12;211(1):6-7. doi: 10.1164/rccm.202407-1480ED.
本文引用的文献
1
Impact of the COVID-19 Pandemic on Outcomes of CAPTURE: A Primary Care Chronic Obstructive Pulmonary Disease Screening Clinical Trial.新冠疫情对CAPTURE研究结果的影响：一项初级保健慢性阻塞性肺疾病筛查临床试验
Ann Am Thorac Soc. 2024 Jan;21(1):176-179. doi: 10.1513/AnnalsATS.202305-478RL.
2
Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee.慢性阻塞性肺疾病：隐匿于众目睽睽之下，慢性阻塞性肺疾病基金会医学与科学咨询委员会声明
Lancet Respir Med. 2023 Dec;11(12):1041-1043. doi: 10.1016/S2213-2600(23)00436-8.
3
Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium.慢性阻塞性肺疾病基金会雾化器联盟关于降低雾化治疗期间呼吸道感染传播风险的指南。
Chest. 2024 Mar;165(3):653-668. doi: 10.1016/j.chest.2023.11.013. Epub 2023 Nov 15.
4
Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings.用于识别美国初级保健环境中慢性阻塞性肺疾病的 CAPTURE 工具的判别准确性。
JAMA. 2023 Feb 14;329(6):490-501. doi: 10.1001/jama.2023.0128.
5
COPD: Providing the right treatment for the right patient at the right time.COPD：在正确的时间为正确的患者提供正确的治疗。
Respir Med. 2023 Feb;207:107041. doi: 10.1016/j.rmed.2022.107041. Epub 2022 Dec 10.
6
Evaluation of Over-the-Counter Portable Oxygen Concentrators Utilizing a Metabolic Simulator.利用代谢模拟器评估非处方便携式氧气浓缩器。
Respir Care. 2023 Apr;68(4):445-451. doi: 10.4187/respcare.10495. Epub 2022 Nov 18.
7
Tobacco industry ownership of pharmaceutical companies: an international survey of people with respiratory disease.烟草行业对制药公司的所有权：一项针对呼吸系统疾病患者的国际调查。
Thorax. 2022 Oct;77(10):1045-1047. doi: 10.1136/thorax-2022-219142. Epub 2022 Aug 15.
8
Developing a patient-driven chronic obstructive pulmonary disease (COPD) research agenda in the U.S.在美国制定以患者为导向的慢性阻塞性肺疾病（COPD）研究议程
J Patient Rep Outcomes. 2021 Dec 4;5(1):126. doi: 10.1186/s41687-021-00399-7.
9
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.通过改良支气管扩张严重程度评分（BSI）和FACED评估的铜绿假单胞菌与非囊性纤维化支气管扩张严重程度的关系：美国支气管扩张和非结核分枝杆菌研究注册库（BRR）研究
Respir Med. 2021 Feb;177:106285. doi: 10.1016/j.rmed.2020.106285. Epub 2020 Dec 24.
10
Nutrition and Markers of Disease Severity in Patients With Bronchiectasis.支气管扩张症患者的营养与疾病严重程度标志物
Chronic Obstr Pulm Dis. 2020 Oct;7(4):390-403. doi: 10.15326/jcopdf.7.4.2020.0178.
Zotero 插件